Candidemia in patients with ventricular assist devices.
During the period 1998-2004, candidemia developed in 7 of 117 ventricular assist device recipients at our hospital, and the associated mortality rate was 71%. Five cases of candidemia were due to Candida parapsilosis, and 2 were due to Candida albicans. Three of the 7 patients with ventricular assist device-associated Candida bloodstream infections were cured, and the device was retained in 2 of the 3 patients.
Shoham
Shmuel
S
Department of Infectious Diseases, Washington Hospital Center, Washington, DC 20010, USA. Shmuel.Shoham@medstar.net
Shaffer
Rebecca
R
Sweet
Leslie
L
Cooke
Richard
R
Donegan
Nancy
N
Boyce
Steven
S
D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D016022:Case-Control Studies; D005260:Female; D016469:Fungemia / Q000188:drug therapy / Q000209:etiology* / Q000401:mortality; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D012189:Retrospective Studies; D012307:Risk Factors
D000935:Antifungal Agents